CD8A and neoplasm: Similarly, the WNT/β-catenin signaling pathway blocks CD8+T cells from entering tumor sites and prevents dendritic cells from activating an immune response, which helps tumors evade the immune system and decreases the success of treatments such as immune checkpoint inhibitors [39].